Veravas, Inc.
Veravas™ is transforming laboratory medicine with a first of its kind, patented antibody detection platform to address unmet clinical needs. This innovative technology uses proprietary nano-sized magnetic beads to preanalytically clean patient samples to remove problematic interferences that can cause false results. With a clean sample, IgA, IgG and IgM immunoglobulins can subsequently be captured and measured against any antigen of interest. This technology will have a profound impact on the performance and speed of development of new serology methods and facilitates the use of saline oral rinse (saliva-based) as an alternative to serum or plasma. Using this technology, Veravas is bringing high value diagnostic tests to market in areas such as infectious disease, cardiovascular, cancer, and neurological diseases that have not been previously possible.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical / Health Care
- Market Focus:
- Globally (various continents)
Our Vision
In real terms, we’re targeting two key issues within our field. The first is the widespread issue of diagnostic interferences – substances like biotin that alter routine test results. The second is the difficulty in measuring biomarkers of low abundance. With our patent-pending technology, we are moving the needle on what is possible to measure, realizing the potential of low abundance biomarkers to better diagnose and treat rare and common diseases.
To make the most of these advances, we’re developing a portfolio of tests, while also providing a platform for companies to advance their novel assays. With this approach, we believe we can make the biggest impact in the shortest amount of time.